Skip to main content
Clinical Trials/NCT05188937
NCT05188937
Completed
Not Applicable

Validity and Reliability of the Dual-task Questionnaire in Multiple Sclerosis Patients

Gazi University1 site in 1 country50 target enrollmentFebruary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Gazi University
Enrollment
50
Locations
1
Primary Endpoint
Validity and reliability of Dual-Task Questionnaire in patients with MS
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

It is important to increase the independence of Multiple Sclerosis (MS) patients in activities of daily living. Almost all activities of daily living require managing many activities at the same time. For example, walking or standing while talking on the phone. There is a need for easily applicable, reliable and valid scales to evaluate dual-task performance in MS patients. Therefore, the aim of this study is to establish the Turkish cultural adaptation, validity and reliability of the Dual-Task Questionnaire scale in MS patients. This study included a total of 50 patients with MS [age (18-65) years]. Dual-task Questionnaire (DTQ), Timed Up and Go test (TUG) with dual-task and Nine Hole Peg test (9-HPT) with dual-task were applied to the patients. The second evaluation (retest) was carried out by the same physiotherapist one week following the first evaluation (test) in order to measure test-retest reliability.

Detailed Description

This study included patients with MS between 0-5,5 score according to the Extended Disability Status Scale (EDSS). DTQ was used to assess the frequency of difficulties associated with daily tasks involving the dual-task. Additionally TUG with dual-task and 9-HPT with dual-task were applied to the patients. An experienced physiotherapist applied all these tests. In order to measure test-retest reliability, a retest was carried out by the same physiotherapist one week following the first evaluation. The construct validity of DTQ was tested by Pearson's correlation coefficient.

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
May 5, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sefa Eldemir

Research Assistant

Gazi University

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Multiple Sclerosis
  • Must be able to ambulatory status (Expanded Disability Status Scale score ≤ 6 )
  • No relapse in the last 3 mounts

Exclusion Criteria

  • Orthopedic problems
  • Visual, perception, and hearing problems

Outcomes

Primary Outcomes

Validity and reliability of Dual-Task Questionnaire in patients with MS

Time Frame: one week

Validity and reliability

Study Sites (1)

Loading locations...

Similar Trials